09/03/2026
RSV: Who needs protection this season?
RSV is a common fall and winter virus that can be serious for infants and older adults. Prevention can significantly reduce severe illness and hospitalization.
š¶ INFANTS
Most infants should be protected through one of two options:
𤰠Maternal RSV vaccine
Given at 32ā36 weeks of pregnancy, typically SeptemberāJanuary, to pass protective antibodies to the baby.
OR
š¶ Infant RSV antibody
Nirsevimab or clesrovimab can protect babies entering their first RSV season when maternal vaccination protection isnāt present. These are long-acting antibodies, not vaccines.
Some high-risk children ages 8ā19 months may also qualify for protection before their second RSV season.
šµ ADULTS
RSV vaccination is recommended for:
* Everyone 75+
* Adults 50ā74 at increased risk, including those with certain chronic conditions, weakened immune systems, frailty, or nursing-home residence
RSV vaccination is not currently annual. If youāve already received it, another dose is not currently recommended.
š Handwashing, covering coughs and sneezes, and avoiding close contact when sick can also help prevent spread.
Not sure what applies to you or your child? Ask us. Signature Health can help you understand which RSV protection is right for your family.
Recommendations align with current AAP/ACIP guidance. This content is educational and not a substitute for personalized medical advice.